glp-1 vagus nerve Increasing GLP‐1 Circulating Levels by Bariatric Surgery or by GLP‐1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different? - Amouyal - 2016 - Journal of Diabetes Research the vagus nerve: a neuroscientist's

Inhaled THC on GLP-1s: If youre navigating both, the method of consumption matters

In such patientsespecially those with heart or kidney diseasethese medications improved blood glucose control, reduced the risk of cardiac and renal complications, promoted weight loss, and lowered the risk of premature death

Case reports and small observational studies describe some patients on semaglutide or tirzepatide reporting reduced alcohol cravings or consumption, but no large randomized controlled trial has tested this as a primary outcome

ywnoci i Lekw) lub odpowiedniki w innych krajach

Circulation 2024;149:450e62

Current evidence regarding the impact of GLP-1 receptor agonists on ophthalmic diseases remains inconsistent. Retinopathy remains the dominant concern Much of the ophthalmic attention surrounding GLP-1 therapies traces back to DR